Playback speed
10 seconds
2021 Updates on MRD in CLL: Chemoimmunotherapy vs. Targeted Approach; IGHV & TP53 Mutations
By
8th Eurasian Hematology Oncology Summit
FEATURING
Robin Foa
By
8th Eurasian Hematology Oncology Summit
FEATURING
Robin Foa
120 views
May 13, 2021
Login to view comments.
Click here to Login